Delivery Order SPE2DB25D3020-SPE2DB25FWKYF
- Not listed
- The Defense Logistics Agency awarded a $1,905.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100 count). The award was competitively procured with no set-aside designation and requires ultimate completion by July 15, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Dextroamphetamine ER 10 mg capsules (90-count supply) valued at $1,149.48, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 15 mg capsules (100 count) with a ceiling value of $1,433.20. This firm fixed-price delivery order, awarded on September 17, 2025, represents a non-set-aside competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,468.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 15 mg capsules (90-count supply) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) valued at $1,063.84 with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order was issued on September 15, 2025, with no set-aside designation. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) valued at $1,381.44. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver the pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,802.34 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units). This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) with a ceiling value of $1,473.61. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- AmerisourceBergen Drug Corp has been awarded a $1,592.96 delivery order by the Defense Logistics Agency (DLA) for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 29, 2025. The award is a competitively procured, firm fixed-price contract with no set-aside designation. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKYFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 10 mg capsules (100-count) with a ceiling value of $1,993.63 under firm fixed price terms. This non-set-aside delivery order was competitively awarded on September 26, 2025, with an ultimate completion date of September 29, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vehicle designated SPE2DX and running through December 2026, which serves as the primary pharmaceutical support mechanism for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that functions as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products including specialty medications, vaccines, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. All of the company's reviewed contract awards have been competitively procured with firm fixed pricing, ranging from small-value transactions to substantial orders exceeding $45,000, reflecting its versatility in fulfilling diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/26/25 |